These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21200116

  • 1. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH, Kayıkçıoğlu M, Yavuzgil O, Kültürsay H, Soydan I.
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [Abstract] [Full Text] [Related]

  • 2. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 3. Characteristics, management and outcomes of patients with acute coronary syndrome and prior coronary artery bypass surgery: findings from the second Gulf Registry of Acute Coronary Events.
    Al-Aqeedi R, Sulaiman K, Al Suwaidi J, Alhabib K, El-Menyar A, Panduranga P, Alshiekh-Ali A, Al Saif S.
    Interact Cardiovasc Thorac Surg; 2011 Dec 23; 13(6):611-8. PubMed ID: 21920933
    [Abstract] [Full Text] [Related]

  • 4. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P, Portuguese Registry on Acute Coronary Syndromes.
    Circulation; 2006 Jul 04; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [Abstract] [Full Text] [Related]

  • 5. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D, Buth KJ, Cox JL, Baskett RJ.
    Am Heart J; 2011 Nov 04; 162(5):836-43. PubMed ID: 22093199
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 04; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 8. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 04; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 9. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ, Zhu J, Liang Y, Zhang Y, Liu LS, Chinese Coordinating Center of OASIS Registry.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 19; 85(3):184-8. PubMed ID: 15854465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
    Dziewierz A, Siudak Z, Rakowski T, Zdzienicka J, Dykla D, Mielecki W, Dubiel JS, Dudek D.
    Cardiol J; 2008 Jan 19; 15(5):451-7. PubMed ID: 18810721
    [Abstract] [Full Text] [Related]

  • 12. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators.
    Eur J Cardiovasc Prev Rehabil; 2006 Aug 19; 13(4):646-54. PubMed ID: 16874158
    [Abstract] [Full Text] [Related]

  • 13. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec 19; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2006 Aug 19; 132(2):392-400. PubMed ID: 16872968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 20. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.
    Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M, CZECH investigators.
    Int J Cardiol; 2007 Jul 10; 119(2):212-9. PubMed ID: 17442424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.